Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Open-label, Randomized, Parallel-group, Multicenter Study of Neoadjuvant Docetaxel(Taxotere®) Plus Cisplatin Plus 5-fluorouracil Versus Neoadjuvant Cisplatin Plus 5-fluorouracil in Patients With Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck
Brief Summary: The Primary Objective is to evaluate the progression-free survival after treatment with docetaxel plus cisplatin plus 5-Fluorouracil (5-FU) (DCF) in comparison with cisplatin plus 5-FU (CF) in patient with locally advanced inoperable SCCHN The Secondary Objective is to evaluate and compare the clinical response rate both before and after radiotherapy, the local symptoms, the duration of response, the time to treatment failure, the survival, the toxicity and the quality of life in the 2 study groups.


Options:
A: Arm Label: Everolimus; Type: EXPERIMENTAL; Interventions: Drug: Everolimus | Arm Label: Placebo; Type: EXPERIMENTAL; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Everolimus; Assigned to Arm(s): Everolimus | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Docetaxel Cisplatin 5-Fluorouracil (DCF); Type: EXPERIMENTAL; Interventions: Drug: DOCETAXEL, Drug: CISPLATIN, Drug: 5-FLUOROURACIL | Arm Label: Cisplatin 5-Fluorouracil (CF); Type: EXPERIMENTAL; Interventions: Drug: CISPLATIN, Drug: 5-FLUOROURACIL | Intervention Type: DRUG; Name: DOCETAXEL; Assigned to Arm(s): Docetaxel Cisplatin 5-Fluorouracil (DCF) | Intervention Type: DRUG; Name: CISPLATIN; Assigned to Arm(s): Cisplatin 5-Fluorouracil (CF), Docetaxel Cisplatin 5-Fluorouracil (DCF) | Intervention Type: DRUG; Name: 5-FLUOROURACIL; Assigned to Arm(s): Cisplatin 5-Fluorouracil (CF), Docetaxel Cisplatin 5-Fluorouracil (DCF)
C: Arm Label: Reduced RT + Pacitaxel/Cisplatin; Type: EXPERIMENTAL; Interventions: Drug: Paclitaxel/Cisplatin, Radiation: Reduced RT | Arm Label: Standard RT + 5-Fluorouracil/Cisplatin; Type: ACTIVE_COMPARATOR; Interventions: Drug: 5-FU/Cisplatin, Radiation: Standard RT | Intervention Type: DRUG; Name: Paclitaxel/Cisplatin; Assigned to Arm(s): Reduced RT + Pacitaxel/Cisplatin | Intervention Type: RADIATION; Name: Reduced RT; Assigned to Arm(s): Reduced RT + Pacitaxel/Cisplatin | Intervention Type: DRUG; Name: 5-FU/Cisplatin; Assigned to Arm(s): Standard RT + 5-Fluorouracil/Cisplatin | Intervention Type: RADIATION; Name: Standard RT; Assigned to Arm(s): Standard RT + 5-Fluorouracil/Cisplatin
D: Arm Label: RT+CDDP/5-FU; Type: ACTIVE_COMPARATOR; Interventions: Drug: RT+CDDP/5-FU | Arm Label: RT+CETUXIMAB; Type: EXPERIMENTAL; Interventions: Drug: RT+CETUXIMAB | Arm Label: INDUCTION CTx(TPF)+(RT+CDDP/5-FU); Type: ACTIVE_COMPARATOR; Interventions: Drug: INDUCTION CTx(TPF)+(RT+CDDP/5-FU) | Arm Label: INDUCTION CTx(TPF)+(RT+CETUXIMAB); Type: EXPERIMENTAL; Interventions: Drug: INDUCTION CTx(TPF)+(RT+CETUXIMAB) | Intervention Type: DRUG; Name: RT+CDDP/5-FU; Assigned to Arm(s): RT+CDDP/5-FU | Intervention Type: DRUG; Name: RT+CETUXIMAB; Assigned to Arm(s): RT+CETUXIMAB | Intervention Type: DRUG; Name: INDUCTION CTx(TPF)+(RT+CDDP/5-FU); Assigned to Arm(s): INDUCTION CTx(TPF)+(RT+CDDP/5-FU) | Intervention Type: DRUG; Name: INDUCTION CTx(TPF)+(RT+CETUXIMAB); Assigned to Arm(s): INDUCTION CTx(TPF)+(RT+CETUXIMAB)

Answer: B